← Leaderboards
Lili Chan
Icahn School Of Medicine At Mount Sinai
$1,630,806
Attributed
$3,666,271
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,666,271 · 2
By mechanism
U01$2,713,953 · 1
K23$952,318 · 1
Top collaborators
- Carol R Horowitz3 shared
- Michal L Melamed3 shared
- Girish Nitin Nadkarni3 shared
Most similar at Icahn School Of Medicine At Mount Sinai
Same institution · by research overlap
- Girish Nitin Nadkarni$10,989,187
- Sarah J Miller$5,037,208
- Melissa Diane Aldridge$12,822,818
- Melissa Mazor$1,094,616
- Mone Zaidi$25,912,145
Others in their field
Other Emerging Leaders on “Medical”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Bambra Strokes · Ppd Development Lp$526,656,217
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Lynn Briscoe · Leidos Biomedical Research, Inc.$96,732,394
- Klaus Romero · Critical Path Institute$88,602,036
Research focus
MedicalEnd Stage Renal FailureTrainingLinkKidneyHemodialysisHealth SystemStandardizationMedicineSymptomsSocial SupportResearch PersonnelResourcesSocialCommunitiesEducationAppointmentSocial Health DeterminantsPatient-Focused OutcomesPatient CareLeadFutureMortalityKidney Diseases
Grant awards (8)
INSPIRE: INterventionS for Promoting kIdney tRansplant Empowerment$1,039,311
U01 · FY2025 · DK · contact PI
Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factors$190,147
K23 · FY2025 · DK · contact PI
Renal transplant Equity through Partnership And Structural Transformation (REPAST)$815,580
U01 · FY2024 · DK · contact PI
Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factors$190,147
K23 · FY2024 · DK · contact PI
Renal transplant Equity through Partnership And Structural Transformation (REPAST)$859,062
U01 · FY2023 · DK · contact PI
Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factors$190,147
K23 · FY2023 · DK · contact PI
Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factors$190,099
K23 · FY2022 · DK · contact PI
Improving risk prediction of adverse outcomes in hemodialysis patients by incorporating non-traditional risk factors$191,778
K23 · FY2021 · DK · contact PI